Physiological Regulating Medicine 2009

PRM MESOTHERAPY VS CONVENTIONAL MESOTHERAPY IN CHRONIC LUMBAGO AND LUMBOSCIATICA-RELATED PAIN CONTROL

To ascertain the therapeutic efficacy of some injectable PRM Pain Therapy medicines specifically for cases of non-paretic, chronic lower back pain, 40 patients (23 M; 17 F) were included in a cohort controlled study vs Ketoprofen (KPF), a powerful NSAID also suitable for mesotherapeutic injections over an observation period lasting 6 months (i.e. a treatment period of 1.5 months and a follow-up of 4.5 months). Patients were divided into two Groups according to their clinical and instrumental diagnoses…

THE COMBINED TREATMENT OF CHRONIC VIRAL HEPATITIS B, C AND MIXED B AND C WITH CITOMIX+GUNA-LIVER+ INTERFERON GAMMA 4C

Seventeen patients have been included in this clinical study (9 men and 8 women, aged between 18 – 80): 8 of them were diagnosed with chronic viral hepatitis B (HVBC), 7 with chronic viral hepatitis C (HVCC) and 2 patients with mixed chronic viral hepatitis B+C (HVBC+HVCC) – the experimental Group. The control Group is made up of 16 patients (10 men and 6 women, aged between 27 and 72): 6 diagnosed with HVBC, 8 with HVCC and 2 patients with mixed chronic viral hepatitis B+C…

CITOMIX IN THE PREVENTION OF THE MOST COMMON COMPLICATIONS OF CHICKENPOX IN PEDIATRIC AGE

Chickenpox is a mainly pediatric, epidemic infectious disease that is usually of limited clinical importance, though it can be associated with complications or leave sequelae. The etiological agent is the varicella Zoster virus (VZV). – This study was conducted on 106 pediatric patients (M/F; mean age 4 years and 4 months) to evaluate the efficacy of CITOMIX in the prevention of the most common complications developing after acquiring this herpes infection. Such postvaricella diseases, which are generally of bacterial etiology, affecting the respiratory apparatus in immunocompetent children, are on the increase…
CITOMIX VS IMMUCYTAL IN THE PREVENTION AND THERAPY OF ACUTE RESPIRATORY INFECTIONS IN PEDIATRIC AGE

Acute respiratory infections, better known as ARTI (Acute Respiratory Tract Infections), are a major concern in pediatric age from both the epidemiological and the economic and social standpoints, given the considerable related costs. – This clinical trial was carried out on 213 children (112 F; 101 M) between 3 and 8 years of age to assess the effectiveness of a PRM + Homotoxicological therapy (not precluding the use of allopathic medicines a priori) vs a conventional therapy for the prevention and treatment of ARTI. During the year prior to the trial, all patients had a positive history of RRI…
TREATMENT WITH CITOMIX™ OF PATIENTS WITH HVBC, HVCC AND HVBC+HVCC

20 patients have been included in the study (15 men and 5 women, aged between 18 and 51): 9 were diagnosed with chronic viral hepatitis B (HVBC), 10 diagnosed with chronic viral hepatitis C (HVCC), and 1 with mixed chronic viral hepatitis B+C (HVBC+HVCC). The diagnosis has been confirmed by laboratory tests [in HVBC patients, anti-HBs (AgHBs, AgHBe, anti-HBe, anti-HBc) and in HVCC (anti-HVC IgM and anti-HVC)]. The treatment with Citomix™ lasted three months:..

INTERFERON ALPHA 4C AND INTERFERON GAMMA 4C: THEIR THERAPEUTIC SYNERGY IN LIVER PATHOLOGIES

This study concerns the evolution of 11 patients with hepatitis C under treatment with Interferon alpha 4C, Interferon Gamma 4C, Interferon gamma 30 C for a period of 6 months. The evaluation is based on the clinical evolution as well on lab tests. It was taken into consideration the presence of the markers for hepatitis C, AB anti HCV (EIA) qualitative and HCV – RNA quantitative (real-time CPR), at the beginning and end of treatment. The dynamic evolution of biochemical tests reflecting the liver functional state…